Scott Langille

Scott Langille

Nessuna posizione attualmente
69 anni
Health Technology
Consumer Services
Utilities

Profilo

Scott M.
Langille
worked as Director-Corporate Finance at Biovail Corp.
Served as CFO, Director & Head-Investor Relations at Aralez Pharmaceuticals Canada, Inc. from 2011 to 2016.
Held the position of Finance Director at AltiMed Pharmaceuticals Co. and Biovail Pharmaceuticals Canada.
Worked as Chief Financial Officer at Sparta Capital Ltd., Sernova Biotherapeutics, Inc. from 2016 to 2018, Wayland Group Corp., ViRexx Medical Corp.
from 2006 to 2007, Cipher Pharmaceuticals, Inc. from 2020 to 2022, and Pure Global Cannabis, Inc. in 2020.
Held the role of Vice President at Biovail Pharmaceuticals LLC and Controller at Zimmer of Canada Ltd. Education includes undergraduate studies at Toronto Metropolitan University and an MBA from the University of Toronto.

Precedenti posizioni note di Scott Langille

SocietàPosizioneFine
CIPHER PHARMACEUTICALS INC. Direttore Finanziario/CFO 15/08/2022
PURE GLOBAL CANNABIS INC. Direttore Finanziario/CFO 01/05/2020
SERNOVA BIOTHERAPEUTICS INC Direttore Finanziario/CFO 04/05/2018
TRIBUTE PHARMACEUTICALS CANADA INC Direttore Finanziario/CFO 01/01/2016
Direttore Finanziario/CFO 01/05/2007
Vedi nel dettaglio l'esperienza di Scott Langille

Formazione di Scott Langille

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

16

Relazioni di 1° grado

14

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private14

Health Technology

Health Technology

Utilities

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

AltiMed Pharmaceuticals Co.

Zimmer of Canada Ltd.

Distribution Services

Health Technology

  1. Mercati
  2. Insiders
  3. Scott Langille